Dti-mri findings in synthetic cannabinoid users.

Creative Commons License

Gökharman F., Aydin S., Paltun S., Fatihoğlu E., Yalçin Ş., Koşar P.

Turkish journal of medical sciences, vol.50, pp.1022-1027, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 50
  • Publication Date: 2020
  • Doi Number: 10.3906/sag-1905-5
  • Journal Name: Turkish journal of medical sciences
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1022-1027
  • Keywords: Bonzai, synthetic cannabinoids, white matter, diffusion tensor imaging, WHITE-MATTER ABNORMALITIES, EARLY-ONSET SCHIZOPHRENIA, MARIJUANA USE, PHARMACOLOGY
  • Erzincan Binali Yildirim University Affiliated: Yes


Background/aim: Synthetic cannabinoids (SCs) are full agonists of both cannabinoid receptors. Conventional magnetic resonance imaging (MRI) findings of SC users are mainly defined as diffusion restriction and T2/FLAIR hyperintensity. Diffusion tensor imaging (DTI) studies examining SC users have shown contradictory results. The aim of this study was to define white matter (WM) changes of SC users using DTI.